Clinical trial
Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for…
NCT00497315 · University Hospital, Antwerp, Other · Completed
Key facts
| NCT number | NCT00497315 |
|---|---|
| Title | Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Official title | A Randomized Multicenter Phase II Study Of Induction Therapy With Pemetrexed And Cisplatin Followed By Chemoradiation With Pemetrexed Versus Chemoradiation With Pemetrexed Followed By Consolidation Therapy With Pemetrexed And Cisplatin In Patients With Stage III Non-Small Cell Lung Cancer: Paccora… |
| Acronym | PACCORA |
| Lead sponsor | University Hospital, Antwerp, Other |
| Collaborators | Universiteit Antwerpen Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | combination chemotherapy (pemetrexed + cisplatin), thoracic irradiation + pemetrexed |
| Enrollment | 30 |
| Start date | Feb 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jul 6, 2007 |
| Last update posted | Apr 10, 2009 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: